Ugh - what a triple whammy - three well known bios that went splat (so far) - ARNA/AMRN still have decent to great chances of recovering, but MNKD is roadkill - I never thought they had a chance, FDA was clearly not a fan of Al - what did they get, 3 CRLs before finally gaining approval, only to see what many pundits expected, horrible sales? I thought about buying some as a spec at one point, but after talking to my little brother and his wife about MNKD's product (they have a daughter with Down's and diabetes), they had zero interest in it "she's used to injections, we have a routine down pat, and she probably wouldn't like inhaling powder, might make her choke or cough" they said, so I stayed out (thank god).
Market Data 
Markets 
AI
